# Treatment of Anemia in Patients With Very Low, Low or Intermediate Risk Myelodysplastic Syndromes With CA-4948

> **NCT05178342** · PHASE2 · TERMINATED · sponsor: **University of Leipzig** · enrollment: 38 (actual)

## Conditions studied

- Myelodysplastic Syndromes
- Anemia

## Interventions

- **DRUG:** CA-4948

## Key facts

- **NCT ID:** NCT05178342
- **Lead sponsor:** University of Leipzig
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2022-01-01
- **Primary completion:** 2024-07-31
- **Final completion:** 2024-07-31
- **Target enrollment:** 38 (ACTUAL)
- **Why stopped:** Prematurely according to trial protocol
- **Last updated:** 2024-08-13

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05178342

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05178342, "Treatment of Anemia in Patients With Very Low, Low or Intermediate Risk Myelodysplastic Syndromes With CA-4948". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT05178342. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*